Search results

Articles (5)

Journals (0)

1-5 of 5 results for ASAS20

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published March, 2025

Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis: A Randomised,Double-blind,Placebo-controlled Trial

Harish BV, Rasmi Ranjan Sahoo, Samanyoya Gochhait [...]

Indian Journal of Rheumatology

Free accessResearch articleFirst published October, 2014

Effects and Safety of Allogenic Mesenchymal Stem Cell Intravenous Infusion in Active Ankylosing Spondylitis Patients who Failed NSAIDs: A 20-Week Clinical Trial

Peng Wang, Yuxi Li, Lin Huang [...]

Cell Transplantation

Open accessResearch articleFirst published 2024

Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study

Uta Kiltz, Xenofon Baraliakos, Jan Brandt-Jürgens [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2023

Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis

Martin Rudwaleit, Pedro M. Machado, Vanessa Taieb [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessReview articleFirst published June, 2026

Advances in Axial Spondyloarthritis Treatment: The Role of Janus Kinase Inhibitors

Fatrian Dwicahya, Cahyo Wibisono Nugroho, Naufalluthfi Widodo

Indian Journal of Rheumatology

Search results

Articles (5)

Journals (0)

1-5 of 5 results for ASAS20

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published March, 2025

Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis: A Randomised,Double-blind,Placebo-controlled Trial

Harish BV, Rasmi Ranjan Sahoo, Samanyoya Gochhait [...]

Indian Journal of Rheumatology

Free accessResearch articleFirst published October, 2014

Effects and Safety of Allogenic Mesenchymal Stem Cell Intravenous Infusion in Active Ankylosing Spondylitis Patients who Failed NSAIDs: A 20-Week Clinical Trial

Peng Wang, Yuxi Li, Lin Huang [...]

Cell Transplantation

Open accessResearch articleFirst published 2024

Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study

Uta Kiltz, Xenofon Baraliakos, Jan Brandt-Jürgens [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2023

Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis

Martin Rudwaleit, Pedro M. Machado, Vanessa Taieb [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessReview articleFirst published June, 2026

Advances in Axial Spondyloarthritis Treatment: The Role of Janus Kinase Inhibitors

Fatrian Dwicahya, Cahyo Wibisono Nugroho, Naufalluthfi Widodo

Indian Journal of Rheumatology